Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/06/2012CA2550868C Spirocyclic cyclohexane derivatives with affinity for the orl1-receptor
03/06/2012CA2543308C Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
03/06/2012CA2540225C Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
03/06/2012CA2530632C Inhalable formulations for treating pulmonary hypertension and methods of using same
03/06/2012CA2525628C New benzimidazole derivatives
03/06/2012CA2525383C Use of heterocyclic compounds as scce inhibitors
03/06/2012CA2523245C Indole acetic acid derivatives and their use as pharmaceutical agents
03/06/2012CA2514539C Process for producing coated preparation
03/06/2012CA2513088C Deuterated catecholamine derivatives and medicaments comprising said compounds
03/06/2012CA2506617C Colon cancer metastasis inhibitor
03/06/2012CA2498754C Benzimidazolones and their use as cytokine inhibitors
03/06/2012CA2496362C Analogues of vitamin d
03/06/2012CA2486055C Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/06/2012CA2485532C Process for the preparation of 2-methyl piperazine derivatives
03/06/2012CA2480666C Tnp-470 polymer conjugates and use thereof
03/06/2012CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
03/06/2012CA2468664C Ketorolac tromethamine compositions for treating or preventing ocular pain
03/06/2012CA2465133C Low concentration of peroxide for treating or preventing vaginal infections
03/06/2012CA2454592C Stable ready-to-use dosage forms containing coloring matter and active chlorine, and methods of making and using same as disinfectants
03/06/2012CA2452881C Novel bicyclic and tricyclic cannabinoids
03/06/2012CA2452008C Ltb4 as vaccine adjuvant
03/06/2012CA2446705C Compositions of quinoxaline-based therapeutic agents and fatty acids having enhanced pharmacokinetic characteristics
03/06/2012CA2446550C Abuse-resistant controlled-release opioid dosage form
03/06/2012CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries
03/06/2012CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
03/06/2012CA2348998C Lipoic acid derivatives and their use in treatment of disease
03/06/2012CA2290944C Pgc-1, a novel brown fat ppar.gamma. coactivator
03/03/2012CA2751306A1 Methods for controlling blood-glucose levels in insulin-requiring subjects
03/01/2012WO2012027712A2 Potent and selective inhibitors of hepatitis c virus
03/01/2012WO2012027710A2 Compounds that modulate intracellular calcium
03/01/2012WO2012027704A1 Mir-33 inhibitors and uses thereof
03/01/2012WO2012027695A1 Methods and compositions for preventing or treating obesity
03/01/2012WO2012027693A2 Pharmaceutical compositions comprising poh derivatives
03/01/2012WO2012027675A2 Poly(beta-amino alcohols), their preparation, and uses thereof
03/01/2012WO2012027603A2 Therapeutic consumable compositions for reduction of facial flush effect incident to alcohol consumption in persons with deficient activity of the aldehyde dehydrogenase gene-aldh2
03/01/2012WO2012027601A2 Methods targeting mir-33 micrornas for regulating lipid metabolism
03/01/2012WO2012027579A1 Synthetic triterpenoid derivatives
03/01/2012WO2012027564A1 Substituted hydroxamic acids and uses thereof
03/01/2012WO2012027557A1 SELECTIVE INHIBITION OF β 1- ADRENERGIC RECEPTORS FOR THE TREATMENT OF PEDIATRIC HEART FAILURE
03/01/2012WO2012027555A2 Glycated cd59 peptides, their preparation, and uses thereof
03/01/2012WO2012027543A1 Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof
03/01/2012WO2012027537A1 Use of a receptor-type kinase modulator for treating polycystic kidney disease
03/01/2012WO2012027536A1 Combination of anti-ctla4 antibody with braf inhibitors for the synergistic treatment of proliferative diseases
03/01/2012WO2012027521A1 Pesticidal compositions
03/01/2012WO2012027514A2 Compositions and methods for cardiac therapy
03/01/2012WO2012027495A1 Piperazinylpyrimidine analogues as protein kinase inhibitors
03/01/2012WO2012027482A2 Compounds, compositions and methods related to ppar antagonists
03/01/2012WO2012027481A1 Compounds for treatment of cancer
03/01/2012WO2012027467A1 RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
03/01/2012WO2012027462A2 Compositions and methods for treating neoplasia
03/01/2012WO2012027445A1 Methods of administering an egfr inhibitor
03/01/2012WO2012027438A1 Pharmaceutical combination of a vegfr inhibitor and a mek inhibitor useful for treating cancer
03/01/2012WO2012027392A2 Antimetastatic compounds
03/01/2012WO2012027378A2 Particles for drug delivery and other applications
03/01/2012WO2012027359A1 Methods for treating antipsychotic-induced weight gain
03/01/2012WO2012027331A1 Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
03/01/2012WO2012027326A2 Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin
03/01/2012WO2012027322A1 Oxadiazole inhibitors of leukotriene production
03/01/2012WO2012027289A1 Aminopyridine- and aminopyrimidinecarboxamides as cxcr2 modulators
03/01/2012WO2012027281A1 Methods for enhancing cognition and/or memory using maltodextrins
03/01/2012WO2012027242A1 High flux microfiltration membranes with virus and metal ion adsorption capability for liquid purification
03/01/2012WO2012027240A1 Fused tricyclic inhibitors of mammalian target of rapamycin
03/01/2012WO2012027239A1 NOVEL PYRAZOLO[1,5-a]PYRROLO[3,2-e]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/01/2012WO2012027237A1 Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy
03/01/2012WO2012027236A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/01/2012WO2012027234A1 Fused tricyclic inhibitors of mammalian target of rapamycin
03/01/2012WO2012027230A1 Facially amphiphilic compounds, compositions, and uses thereof in treating cancer
03/01/2012WO2012027216A1 An efficient, catalytic and scalable method to produce chlorine dioxide
03/01/2012WO2012027214A1 Synbiotic product
03/01/2012WO2012027032A1 Method for stimulating foxp3+ regulatory t cell expression of cd39
03/01/2012WO2012026988A2 Dendrimeric peptides, pharmaceutical compositions and methods of using the same
03/01/2012WO2012026928A1 Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
03/01/2012WO2012026914A1 Methods and compositions for treating internal and external hemorrhoids
03/01/2012WO2012026908A2 Cefpodoxime proxetil formulations comprising taste regulating agent
03/01/2012WO2012026907A2 Cefpodoxime proxetil formulations
03/01/2012WO2012026906A1 New tiotropium bromide crystal and its production method
03/01/2012WO2012026904A1 A single unit dosage form on the basis of a combination comprising donepezil and ginkgo biloba extract
03/01/2012WO2012026903A1 Synergistic compositions comprising memantine and gingko - biloba extract
03/01/2012WO2012026902A1 Combinations comprising donepezil, memantine and gingko biloba extract
03/01/2012WO2012026897A1 A process for the preparation of imatinib base
03/01/2012WO2012026896A1 Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof
03/01/2012WO2012026813A2 Analogs of geranylgeranylacetone (gga) and uses thereof
03/01/2012WO2012026766A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
03/01/2012WO2012026765A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
03/01/2012WO2012026665A1 Novel tacrolimus derivatives, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same
03/01/2012WO2012026663A1 Anticancer supplement including undecylenic acid, conjugated linoleic acid, and/or a conjugated linoleic acid isomer
03/01/2012WO2012026662A1 Composition including undecylenic acid and/or conjugated linoleic acid for the prevention and treatment of degenerative neurological disorders
03/01/2012WO2012026641A1 Composition for preventing or treating dementia
03/01/2012WO2012026639A1 Novel compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient
03/01/2012WO2012026614A1 Composition suppressing matrix-metalloproteinase activity
03/01/2012WO2012026609A1 Aqueous composition for ophthalmic administration
03/01/2012WO2012026565A1 Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
03/01/2012WO2012026511A1 Pharmaceutical composition
03/01/2012WO2012026495A1 Novel hydantoin derivative and medicinal agent comprising same as active ingredient
03/01/2012WO2012026491A1 Pluripotent stem cell cardiomyocyte differentiation-promoting agent
03/01/2012WO2012026468A1 Crosslinked hyaluronic acid composition and self-crosslinking hyaluronic acid particles
03/01/2012WO2012026434A1 Crystal of tricyclic pyrazolopyrimidine derivative
03/01/2012WO2012026433A1 Free crystal of tricyclic pyrazolopyrimidine derivative
03/01/2012WO2012026403A1 Condensed ring compound
03/01/2012WO2012026106A1 Optically active novel anti-inflammatory compound and method for producing same
1 ... 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 ... 7860